Related Experiment Videos

Fulminant Clostridium Septicum myonecrosis in well controlled diabetes: a case report

Huy A Tran1, Esther Myint

  • 1Division of Clinical Chemistry Hunter Area Pathology Service, John Hunter Hospital, Locked Bag 1, Hunter Region Mail Centre, Newcastle, New South Wales, Australia 2310. huy.tran@hnehealth.nsw.gov.au.

Journal of Medical Case Reports
|October 31, 2007
PubMed

Insights

Diabetic myonecrosis caused by Clostridium Septicum is rare but deadly. Vigilance for sepsis is crucial, even in well-controlled diabetics, due to the organism's opportunistic nature.

Area of Science:

  • Infectious Diseases
  • Endocrinology
  • Gastroenterology

Background:

  • Diabetic myonecrosis, particularly with Clostridium Septicum, is a rare but severe condition.
  • Clostridium Septicum is a commensal gastrointestinal bacterium that can cause severe infections.
  • Risk factors include immunosuppression, neutropenia, occult malignancy, and poorly controlled diabetes.

Purpose of the Study:

  • To report an unusual case of diabetic myonecrosis with Clostridium Septicum.
  • To highlight the opportunistic nature of Clostridium Septicum infections.
  • To emphasize the need for high clinical suspicion in diabetic patients presenting with sepsis.

Main Methods:

  • Case report presentation.
  • Review of relevant medical literature.
  • Analysis of patient's clinical presentation and risk factors.

Main Results:

  • The case involved a patient with diabetic myonecrosis due to Clostridium Septicum.
  • The patient presented with minimal risk factors, including only mild neutropenia.
  • This underscores the organism's ability to cause severe disease opportunistically.

Conclusions:

  • Clostridium Septicum can cause severe diabetic myonecrosis even with limited risk factors.
  • A high index of suspicion is warranted for sepsis in diabetic patients, irrespective of glycemic control.
  • Prompt recognition and management are critical due to the high mortality rate associated with this condition.

Related Concept Videos

Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...